The best AlphaSpread alternative for systematic European stock screening is ScreenerHero. It covers 17,000+ stocks across US, Canadian, and all European exchanges with the fundamental filters value investors use most — without the US-centricity and valuation-model focus that limits AlphaSpread's usefulness for European equity screeners.
Last updated: June 2026.
What AlphaSpread is built for
AlphaSpread is a valuation-focused tool designed around two core features:
DCF and intrinsic value models: AlphaSpread calculates fair value estimates using Discounted Cash Flow models, Relative Valuation (peer multiples), and Benjamin Graham's net-net approach. Users can adjust model inputs and view sensitivity analyses.
Fundamental data access: Per-company pages with financial statement data, ratios, and historical trend charts. The coverage is primarily US-focused, with European company data available but less complete.
For investors who want to validate a specific stock's valuation with a structured model, AlphaSpread is a genuinely useful tool. It streamlines the DCF process with pre-loaded financial data.
Why investors look for AlphaSpread alternatives
It's not a screener — it's a company-level research tool
AlphaSpread is designed for investigating a specific company you already know about, not for discovering candidates across thousands of stocks. You enter a ticker and get a valuation model. You cannot filter 17,000 stocks by EV/EBITDA below 10 and ROE above 15% and get a sorted shortlist.
For investors whose process is screener-first — filter broadly, build a shortlist, then research individual names — AlphaSpread is the wrong starting point.
European coverage is secondary
AlphaSpread's data depth for European mid and small caps is inconsistent. Large European blue chips are reasonably covered; for companies below €500M market cap on continental exchanges (Euronext Growth, First North, EGM), data gaps are common. For systematic European equity screening, this is a significant limitation.
The model outputs require investment
DCF outputs depend heavily on the assumptions entered — revenue growth rate, terminal growth rate, and discount rate. AlphaSpread's default assumptions may not match your investment thesis. Using it well requires revisiting every model input, which is time-consuming when evaluating dozens of candidates.
AlphaSpread vs. the alternatives: comparison table
| Feature | AlphaSpread | ScreenerHero | GuruFocus | Finviz | TIKR |
|---|---|---|---|---|---|
| DCF valuation model | ✓✓✓ | ✗ | ✓ | ✗ | ✗ |
| Systematic screener | ✗ | ✓ | ✓ | ✓ | ✓ |
| European coverage | Partial | ✓ 17,000+ | Limited | ✗ | Partial |
| European small caps | Limited | ✓ | ✗ | ✗ | Partial |
| Free tier | ✓ Limited | ✓ No account | ✓ Limited | ✓ | ✓ Freemium |
| Saved screens | ✗ | ✓ | ✓ | ✓ Elite | ✓ |
| Graham net-net screen | ✓ Per-company | Via filters | ✓ | Via filters | Via filters |
| Price (paid) | ~$10–30/mo | €29/mo | $59.99/mo | $39.50/mo | $10–55/mo |
Data as of June 2026.
The best AlphaSpread alternatives by use case
For systematic fundamental screening with European coverage: ScreenerHero
ScreenerHero is the direct replacement for investors who want what AlphaSpread doesn't offer: a filter-and-sort screener that works across the full European equity universe.
What you gain: Filter thousands of European stocks simultaneously by P/E, EV/EBITDA, P/B, FCF yield, ROE, ROIC, margins, leverage, and growth metrics. Sort the results. Save screens that persist between sessions. Apply the same filters to US, Canadian, and European exchanges in a single view.
What you give up: AlphaSpread's structured DCF modelling and fair value output. ScreenerHero doesn't build DCF models — it gives you the raw metrics to build your own judgment.
Best for: Investors who want to screen first and value later — building a candidate list with fundamental filters, then researching individual names to assess intrinsic value.
For DCF models with US focus: GuruFocus
If AlphaSpread's DCF feature is your primary use case but its European coverage doesn't serve you well, GuruFocus has a more complete US-focused DCF and intrinsic value modelling toolset. The GuruFocus DCF calculator, "owner earnings" model, and GF Value (proprietary fair value estimate) are more sophisticated than AlphaSpread's defaults for US stocks.
Best for: US-focused value investors who want structured intrinsic value models alongside screening.
For European fundamental depth + historical data: TIKR
TIKR provides 20-year historical financial statement data with a screener overlay. For investors who want to analyse AlphaSpread-like fundamental trends (10-year margin progression, ROIC history, per-share metrics) across European companies, TIKR's historical depth is relevant.
Best for: Investors who conduct 10-year fundamental analysis on each candidate as part of their research process.
For quick relative valuation with European coverage: Stockopedia
Stockopedia's StockRank system applies pre-computed composite scores (Quality, Value, Momentum) across European equities. This is a shortcut to identifying relatively cheap, high-quality names without running individual DCF models. Less rigorous than AlphaSpread's modelling but faster for building a shortlist.
Best for: European investors who want pre-ranked quality/value/momentum scores without building models from scratch.
Replicating AlphaSpread's most useful features with alternatives
Replicating the DCF framework
AlphaSpread's value as a DCF tool comes from pre-loading financial data into a model structure. To replicate this without AlphaSpread:
- Use ScreenerHero (or your screener of choice) to identify candidates with the right fundamental profile
- Pull financial statement data from company reports or TIKR
- Build DCF assumptions in a spreadsheet or use GuruFocus's DCF calculator as a starting point
This workflow is more manual but gives you more control over assumptions — AlphaSpread's default inputs often need significant adjustment for European companies.
Replicating the Graham net-net screen
AlphaSpread highlights net-net stocks per company. To replicate this as a systematic screen:
- P/B < 0.6 (price-to-book below 0.6 approximates NCAV discount in most cases)
- Current ratio > 2.0 (current assets exceed current liabilities, providing the NCAV cushion)
- Net Debt/EBITDA < 1.0 (eliminates heavily indebted names)
Running these three filters in ScreenerHero produces the same type of net-net candidate list that AlphaSpread surfaces for individual companies, but across the full European and North American universe simultaneously.
What AlphaSpread does better than screener alternatives
Be honest about what you give up:
Structured DCF with sensitivity analysis: No screener replicates this. AlphaSpread's strength is turning financial data into a populated, adjustable valuation model with a single click. Screeners give you inputs; AlphaSpread gives you an output framework.
Fair value visual: The AlphaSpread "margin of safety" display — showing current price versus fair value estimate with a simple visual — is intuitive for investors who want a quick sanity check on individual positions.
Per-company fundamental history display: The trend charts showing 10-year margins, ROIC, and FCF for individual companies are well-designed for quick qualitative assessment.
Bottom line
AlphaSpread is a valuation tool for companies you've already identified. It is not a discovery tool for finding candidates. For investors who want to screen thousands of European stocks systematically — applying fundamental filters and building ranked candidate lists — a dedicated screener is the prerequisite step. Then AlphaSpread (or a manual DCF model) is the next step for valuing the shortlist.
The tools are complementary, not competing: screen broadly with ScreenerHero or Finviz, then validate the most interesting candidates with AlphaSpread's modelling framework or your own DCF. The gap AlphaSpread cannot fill is European small-cap discovery — and that's where a dedicated European screener is essential.
Frequently asked questions
Is AlphaSpread free?
AlphaSpread offers a free tier with limited access to valuation models and financial data. The paid tiers (typically $10–30/month depending on the plan) unlock full data access, more companies, and additional model features. The free tier is useful for checking AlphaSpread's valuation output on a handful of stocks; for systematic use it requires a paid subscription.
Does AlphaSpread cover European stocks?
AlphaSpread covers European large-cap stocks with reasonable fundamental data. Coverage degrades for European mid and small caps — particularly on alternative markets (Euronext Growth, First North, EGM). For systematic European small-cap screening and valuation, AlphaSpread's data gaps make it unreliable. Dedicated European screeners cover this universe more completely.
What is the best free alternative to AlphaSpread for European stocks?
ScreenerHero's free tier provides full fundamental screening across 17,000+ European and North American stocks with no account required — covering the discovery and filtering workflow that AlphaSpread doesn't offer. For DCF modelling specifically, GuruFocus's free tier provides limited DCF functionality. The most practical approach: screen in ScreenerHero, build DCF models manually or with GuruFocus for the shortlisted candidates.
Can I use AlphaSpread and ScreenerHero together?
Yes — and this is the recommended workflow for thorough European equity research. Use ScreenerHero for broad discovery (filter 17,000+ stocks by fundamental criteria, build a shortlist of 20–50 names), then use AlphaSpread to run structured valuation checks on the most interesting candidates from the shortlist. The two tools are complementary: one finds candidates at scale, the other models individual valuations.
Screen European stocks → — free, no account required. Filter by P/B, EV/EBITDA, ROE, FCF yield across all European exchanges. Build your shortlist before running individual valuations.